Sign inJoin waitlistJoin the waitlist

RM

Rebecca Mcfall

Physician · Advocate Health Care

Credentials: · · · · ·

History

Advocate Health Care
Present

Pediatric Hematology Oncology
Johns Hopkins Hospital
2005–2008
Ann & Robert H Lurie Children's Hospital of Chicago
2002–2005
University of Louisville School of Medicine
1998–2002

Research

Docetaxel, bevacizumab, and gemcitabine for very high risk sarcomas in adolescents and young adults: A single-center experience
Pediatric Blood & Cancer · 2017 · Last of 8 authors · 16 citations

Christopher Kuo
1 paper
KD
Kristen Dalton
1 paper
Marta Batus
1 paper
PK
Paul Kent
1 paper

Clinical trials

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2025–2028
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2025–2030
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
Site PI · Recruiting · Phase 3
Children's Oncology Group
2025–2031
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Site PI · Recruiting · Phase 3
Children's Oncology Group
2025–2029